Upregulation of SOCS-1 by Nutlin-3 in acute myeloid leukemia cells but not in primary normal cells
OBJECTIVE: It has been shown that SOCS-1 plays an important role in the proper control of cytokine/growth factor responses and acts as a tumor suppressor in acute myeloid leukemias. Therefore, the objective of the present study was to evaluate the in vitro effect of treatment with Nutlin-3, a small...
Main Authors: | Veronica Tisato, Alessia Norcio, Claudio Celeghini, Daniela Milani, Arianna Gonelli, Paola Secchiero |
---|---|
Format: | Article |
Language: | English |
Published: |
Faculdade de Medicina / USP
2014-01-01
|
Series: | Clinics |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322014000100068&lng=en&tlng=en |
Similar Items
-
MDM2 antagonists as a novel treatment option for acute myeloid leukemia: perspectives on the therapeutic potential of idasanutlin (RG7388)
by: Khurana A, et al.
Published: (2019-04-01) -
Nutlin3a Contributes to the Cytoplasmic Retention of Androgen Receptor
by: Gulseren Ozduman, et al.
Published: (2018-12-01) -
Dynamic behavior of the p53-Mdm2 core module under the action of drug Nutlin and dual delays
by: Juenu Yang, et al.
Published: (2021-05-01) -
Pharmacological Inhibition of WIP1 Sensitizes Acute Myeloid Leukemia Cells to the MDM2 Inhibitor Nutlin-3a
by: Maria Chiara Fontana, et al.
Published: (2021-04-01) -
The MDM2 ligand Nutlin-3 differentially alters expression of the immune blockade receptors PD-L1 and CD276
by: Ruidong Li, et al.
Published: (2020-08-01)